The era of “miracle” drugs to treat obesity is entering a phase of crude scientific maturity, thanks to the time that has passed since its launch on the market. In this way, despite the years with big headlines pointing to great weight losses with Ozempic, science is now able to provide more answers to the key question What we should ask ourselves: what happens when we stop pricking ourselves?
The problem. When a drug is newly released to the market, long term effects It is something that is not known exactly, since patients need to be taking them long enough to see the effects they cause. And above all the effect that exists when the drug is removed from the body. To answer this with Ozempic we have a study led by the University of Oxford which is not minor at all, since it has analyzed more than 9,300 adults in 37 different clinical trials.
And the conclusion they have been able to draw is quite clear: patients regain weight when they stop treatment at a rate of 0.4 kg per month.
The comparison. At first glance, this figure seems really low, but if we compare it with other methods to lose weight, we see that the magnitude of the problem is not minuscule. The study itself indicates that in behavioral programs, such as a diet and an increase in physical activity, the effect after its withdrawal is an increase of 0.1 kg per month.
This way, the rebound effect of slimming drugs It causes you to return to your initial weight in approximately a year and a half, while a change in eating and sports behavior takes around four years.
New generation drugs. But this is a simple average between the different medications on the market. This implies that within GLP-1 agonists we can see that the most powerful drugs also have a much greater rebound effect.
For example, in the case of Wegovy or Mounjaro, where the initial loss was 14.7kg, the rebound was seen to shoot up to 0.8kg per month. An effect that tells us that the body tries to recover lost ground at twice the speed of previous generation drugs.
Cardiovascular health. Beyond the aesthetic, science pointed out that these drugs had the ability to reduce the risk of heart attacks and improve the metabolic health. But it seems these effects are completely temporary.
Specifically, the study has seen that approximately a year and a half after stopping the medication, the majority of cardiometabolic markers return to their levels before starting treatment. For example, blood pressure increases, diabetes markers reverse their improvement, and total cholesterol also returns to its risk levels.
Why the rebound is so fast. The answer to this could lie in our own biology. Science believes that this effect is due to the fact that by injecting massive doses of GLP-1 agonists (a hormone that is produced in small quantities when we eat) we could be destabilizing our own cell receptors. Or we would even be blocking our body’s natural production of this hormone that gives us satiety.
That is why when withdrawing the drugthe system does not have the ability to produce this hormone again in the same way as before (as if it had to turn the system back on) and that is why the body’s satiety system goes deaf. The result? Well, logically, the appetite returns with great intensity, causing the patient to eat much more food, since they are not satiated and in this way the weight increases again.
The myth of the magic bullet. There are hardly any miracles in medicine, even though we say that these drugs are. And the reality is that these drugs are not the definitive solution for obesity, since real data indicates that the majority of patients stop treatment after 12 months due to its high cost, the fatigue of injecting or side effects.
But in addition, there is no awareness that this treatment is a simple aid to self-regulation, but that logically it must be accompanied by a dietary change and physical activity that must be continued once the treatment is finished. If not, we can be sure that the injections will be of absolutely no use.
A paradigm shift. This meta-analysis marks a turning point. Science tells us that GLP-1 is extraordinarily effective, but it is not a cure. If we treat them as a six-month “crash plan”, we are condemning the patient to a more aggressive yo-yo effect than any miracle diet of the past.
The solution, according to Qi Sun and the Oxford researchers, is not only in the syringe, but in public policy: taxes on ultra-processed foods, aid in the purchase of fruits and vegetables, and urban planning that encourages exercise. Without a change in environment, the drug is just a temporary truce in a war the body is programmed to win.
Images | David Trinks Towfiqu barbhuiya


GIPHY App Key not set. Please check settings